Savannah Thames, APRN
Psychiatric/Mental Health · North Myrtle Beach, SCNPI 1740997956
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 235 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 24.3% of the total.
Across 235 payments — averaging $16.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$962
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$510
- Axsome Therapeutics, Inc.$425
- Vanda Pharmaceuticals Inc.$301
- Neurocrine Biosciences, Inc.$267
- Otsuka America Pharmaceutical, Inc.$245
- plus $1K from 13 others
What the payments were for
- Food & beverage$3,963100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 91 | $962 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $510 |
| Axsome Therapeutics, Inc. | 15 | $425 |
| Vanda Pharmaceuticals Inc. | 14 | $301 |
| Neurocrine Biosciences, Inc. | 14 | $267 |
| Otsuka America Pharmaceutical, Inc. | 13 | $245 |
| Alkermes, Inc. | 11 | $199 |
| Ironshore Pharmaceuticals Inc. | 10 | $194 |
| Corium, LLC | 6 | $131 |
| Johnson & Johnson | 5 | $108 |
| Lundbeck LLC | 4 | $105 |
| Neos Therapeutics, LP | 5 | $100 |
| Noven Therapeutics, LLC | 5 | $99 |
| Tris Pharma Inc | 4 | $79 |
| Supernus Pharmaceuticals, Inc. | 3 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 1 | $29 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
How this compares
$3,963 in reported general payments places this provider in the 85th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 36 | $53,675 |
| TrintellixVortioxetine Hydrobromide | 17 | $18,398 |
| Lurasidone Hcl | 12 | $4,697 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 20 | $2,217 |
| Hydroxyzine Hcl | 51 | $1,984 |
| Methylphenidate ErMethylphenidate Hcl | 22 | $1,049 |
| Oxcarbazepine | 12 | $729 |
| Quetiapine Fumarate | 23 | $551 |
| Bupropion XlBupropion Hcl | 17 | $546 |
| Lamotrigine | 37 | $516 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 12 | $482 |
| Trazodone Hcl | 40 | $477 |
| Alprazolam | 60 | $477 |
| Gabapentin | 12 | $432 |
| Aripiprazole | 20 | $412 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $962 | $53,67536 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $63 | $18,39817 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 354 psychiatric/mental health providers in South Carolina.
Other psychiatric/mental health in North Myrtle Beach
- Mary McManusNorth Myrtle Beach$15K
- Steven KrozerGreenville$139K
- Luron FlemingGreenville$61K
- Cerrissa HugieCharleston$54K
- Karen FulwoodMyrtle Beach$30K
- Taylor CrewsIsle Of Palms$28K
- Lauren DyerGreenville$16K
- Melissa BrownGreenville$16K
- Kelsie FowlerAnderson$15K
- William HendricksGreenville$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.